Myths around asthma remain strong, new research finds

Fewer than half of all Australians can correctly identify asthma as a chronic disease that doesn’t go away, according to new Asthma Australia research.¹ In...

Choosing wisely to achieve medicine safety

The quality use of medicines is vital to ensure a sustainable healthcare system and better health outcomes for consumers. This was the dominant theme at...

Offshore refresher: live and learn

PSA’s Offshore Refresher Conference this year took members to Europe. ECP Sinead Stone MPS went along, courtesy of a grant from Bayer. It was...

Current evidence for medicinal cannabis

Cannabis is the most popular recreational drug used in the world. The use of cannabis or cannabinoids is referred to as medicinal cannabis. Learning objectives...

Management of apathy in patients with Alzheimer’s disease

People diagnosed with Alzheimer’s disease often experience symptoms of apathy, which can be treated by pharmacological and behavioural interventions. The purpose of this evidence...

Ensuring patients’ medical data is secure

The rollout of My Health Record has raised questions surrounding the security of medical data. What measures must be taken in pharmacies to preserve...